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Intro:
• For people with opioid use disorder
(OUD), admission to the hospital can
provide an opportunity to initiate
substance use disorder (SUD) treatment
and preventive care
• In 2016, a multidisciplinary “IMAT”
(integrated medication for addiction
treatment) inpatient team was
established to help treat patients with
SUD
Aims
• Describe inpatients with OUD, including
psychiatric and infectious comorbidities,
who were evaluated by the IMAT team
• Identify areas of need and opportunities
for practice improvement
Methods:
• Retrospective chart review of inpatients
at MMC seen by the IMAT consult service
for illicit opioid use disorder between
7/1/2016 – 6/30/2017.
• Data was recorded directly into a secure
online REDCap database
• Descriptive analysis was performed using
SAS
Discussion:
• Many patients with OUD engaged in
addiction treatment, and had follow up
planned after discharge
• An important further area for
investigation is treatment retention; high
rates of housing instability and
unemployment may be obstacles
• Only 10% of patients were documented
to be offered naloxone kits, with fewer
accepting the prescription. Given
polysubstance use and overdose risk in
this population, naloxone distribution is
an area for improvement
• High rates of hepatitis C co-infection, as
well as low rates of hepatitis B
vaccinations, raise the question of
whether and how these could be
addressed during hospitalization
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Admitted patients with 
known or suspected 
opioid use disorder 
Psychiatry or IMAT consult engages 
IMAT team (N =145)
- 86% have injected drugs in their    
lifetime
- 32% do not have stable housing
- 92% have one or more psychiatric 
co-morbidities
Some have bacterial or 
fungal infections related to 
unsafe injection practices 
 treatment and 
prevention indicated
- 57% patients had one or 
more infections
- 18% had endocarditis
50% of these patients underwent surgical 
intervention
- Minimal documentation 
regarding  harm reduction 
practices knowledge and 
education
Most are at risk of 
communicable infection 
 screening and 
vaccination indicated
- 50% had hepatitis C
80% of those aware of diagnosis
7% of those aware had previously 
received treatment
- Only 35% patients with 
clear indication for 
hepatitis B vaccine (N=37) 
received a dose
Summary of results:
This analysis showed that hospitalized patients with opioid use 
disorder who received multidisciplinary IMAT services had high 
utilization of medication for addiction treatment.  
However, there were low implementation of preventive 
measures to decrease risk of overdose fatalities and injection-
related infections.
Most are at risk for 
overdose  overdose 
prevention indicated
- 10% of patients offered 
naloxone
- 62% had new or adjusted MAT plan on discharge
- 83% had IMAT or psychiatric provider planned on discharge
21%
22%
54%
3%
79%
MAT PLANNED ON DISCHARGE:
None
Methadone
Buprenorphine
Naltrexone
Limited ability to capture behavioral characteristics
- 12% of patients left hospital early 
(against medical advice)
- 10% had code green (elopement) or code grey 
(security) events
Table 1. Additional characteristics of 145 patients seen by IMAT 
team between July 2016 and July 2017, N (%).
Female 57 (39.3)
Pregnant 10 (17.5)
Age, years
<19 1 (0.7)
19-30 36 (24.8)
31-50 88 (60.6)
≥51 20 (13.8)
Unemployed1 88 (60.7)
Homeless or unstable housing1 47 (32.4)
Rural2,3 29 (21.0)
History of psychiatric comorbidities4
Psychosis 10 (6.9)
Depression 93 (64.1)
Anxiety 80 (55.2)
Bipolar disorder 20 (13.8)
PTSD 32 (22.1)
ADHD 32 (22.1)
Personality disorder 18 (12.4)
Admission duration, days, median 
[range]
10 [2-129]
Discharge disposition
Home (including homeless shelter) 117 (80.7)
Left hospital early (against medical 
advice)
18 (12.4)
Rehab 7 (4.8)
Hospice or death 1 (0.7)
Other 2 (1.4)
Behavioral contract established 33 (22.8)
Current substance use
Illicit opioid use 87 (60.0)
Cocaine 83 (57.2)
Benzodiazepines 26 (18.1)
Cannabis 46 (31.7)
Controlled substance prescriptions 
prior to admission
None 71 (49.3)
Opioids 21 (14.5)
Buprenorphine5 38 (26.4)
Benzodiazepines 23 (15.9)
Amphetamines 15 (10.3)
History of injection drug use
Yes 119 (85.6)
Denied, but suspected 2 (1.4)
Current injection drug use
Yes 76 (54.3)
Denied, but suspected 12 (8.6)
Bacterial Infections4
Cellulitis or osteomyelitis 30 (20.7)
Bacteremia 37 (25.5)
Endocarditis 26 (17.9)
Required valve surgery 13 (50.0)
Spinal epidural abscess 11 (8.1)
Septic joint 10 (6.9)
Pneumonia 25 (17.2)
Other 20 (16)
Infectious disease consultation 59 (40.7)
Viral coinfections
Hepatitis C
Not tested 51 (35.2)
Negative 22 (15.2)
Positive 72 (49.7)
Diagnosed during admission 14 (18.7)
Hepatitis B
Not tested 65 (45.5)
Positive 15 (10.5)
Hepatitis A
Not tested 109 (75.2)
Positive 8 (5.5)
HIV
Not tested 59 (40.7)
Positive 2 (1.4)
Missed Hepatitis A vaccination6 18 (64.3)
Missed Hepatitis B vaccination6 24 (64.9)
1 Unknown status: Employment, N=  ; Housing, N=
2 Missing data: rural, N=7
3 Rural status of non-incarcerated Maine and New Hampshire 
residents was classified using Rural-Urban Continuum Codes for their 
county of residence. 
4 May report more than one diagnosis
5 Includes buprenorphine and buprenorphine/naltrexone
6 Percentages reported out of patients for whom vaccine was 
determined with certainty be indicated (negative serologies)
Abbreviations: ADHD, Attention Deficit Hyperactivity Disorder; ED, 
emergency department; PTSD, post-traumatic stress disorder; MAT, 
medication for addiction treatment
